Ovid Therapeutics logo

Ovid Therapeutics Share Price Today

(NASDAQ: OVID)

Ovid Therapeutics share price is $0.34 & ₹29.01 as on 25 Apr 2025, 2.30 'hrs' IST

$0.34

0.01

(3.63%)

Market is closed - opens 7 PM, 25 Apr 2025

View live Ovid Therapeutics share price in Dollar and Rupees. Guide to invest in Ovid Therapeutics stock from India, including Indian investor sentiment. Get details on Indian mutual funds investing in Ovid Therapeutics, along with analyst recommendations, forecasts, and comprehensive financials.

Ovid Therapeutics share price movements

  • Today's Low: $0.32
    Today's High: $0.36

    Day's Volatility :10.78%

  • 52 Weeks Low: $0.24
    52 Weeks High: $3.45

    52 Weeks Volatility :92.97%

Ovid Therapeutics (OVID) Returns

PeriodOvid Therapeutics IncIndex (Russel 2000)
3 Months
-55.99%
0.0%
6 Months
-72.62%
0.0%
1 Year
-89.19%
0.0%
3 Years
-88.62%
-8.8%

Ovid Therapeutics (OVID) Key Statistics

in dollars & INR

Previous Close
$0.325
Open
$0.3483
Today's High
$0.3591
Today's Low
$0.3204
Market Capitalization
$20.5M
Today's Volume
$696.8K
52 Week High
$3.45
52 Week Low
$0.2425
Revenue TTM
$566.0K
EBITDA
$-57.8M
Earnings Per Share (EPS)
$-0.37
Profit Margin
0.0%
Quarterly Earnings Growth YOY
0.0%
Return On Equity TTM
-33.88%

How to invest in Ovid Therapeutics Stock (OVID) from India?

It is very easy for Indian residents to invest directly in Ovid Therapeutics from India. Indian investors can open a free US stocks account on the INDmoney app. You can find live prices of the Ovid Therapeutics stock in both Indian Rupees (INR) and US Dollars (USD). Search for Ovid Therapeutics or OVID on the INDmoney app and click on Buy or SIP. You can invest by choosing quantities of shares of Ovid Therapeutics or rupee/ dollar value or set up a fixed SIP amount to be invested every month or week.

For example: You can easily buy Rs.100 worth of Ovid Therapeutics shares which would translate to 2.509 fractional shares of Ovid Therapeutics as of today. Learn more about fractional investing.

Indians can now also easily transfer and add money to their US stocks account via the INDmoney app. Invest in US Stocks from India, including recognised companies like Ovid Therapeutics, in just a few clicks!

Returns in Ovid Therapeutics (OVID) for Indian investors in Rupees

The Ovid Therapeutics stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

Investment Value

₹1,00,000

  • 1Y

  • 3Y

  • 5Y

  • 7Y

  • 10Y

Ovid Therapeutics investment value today

Current value as on today

₹13,768

Returns

₹86,232

(-86.23%)

Returns from Ovid Therapeutics Stock

₹88,629 (-88.63%)

Dollar Returns

₹2,397 (+2.4%)

Indian investors sentiment towards Ovid Therapeutics (OVID)

8%

Period: Mar 25, 2025 to Apr 24, 2025. Change in 30 Days versus previous period

Search interest for Ovid Therapeutics Stock from India on INDmoney has increased by 8% in the last 30 days, reflecting an upward trend in search activity.

Global Institutional Holdings in Ovid Therapeutics

  • Takeda Pharmaceutical Co Ltd

    10.60%

  • Rubric Capital Management LP

    7.48%

  • BlackRock Inc

    5.53%

  • Bvf Inc

    5.42%

  • Madison Avenue Partners, LP

    5.24%

  • Vanguard Group Inc

    4.43%

Analyst Recommendation on Ovid Therapeutics

Rating
Trend

Buy

    87%Buy

    12%Hold

    0%Sell

Based on 16 Wall street analysts offering stock ratings for Ovid Therapeutics(by analysts ranked 0 to 5 stars)

Analyst Forecast on Ovid Therapeutics Stock (OVID)

What analysts predicted

Upside of 841.18%

Target:

$3.20

Current:

$0.34

Insights on Ovid Therapeutics Stock (Ticker Symbol: OVID)

  • Price Movement

    In the last 7 days, OVID stock has moved up by 12.0%
  • Decreasing Revenue

    Revenue is down for the last 2 quarters, 173.0K → 76.0K (in $), with an average decrease of 56.1% per quarter
  • Increasing Net Profit

    Netprofit is up for the last 2 quarters, -14.00M → -9.25M (in $), with an average increase of 51.4% per quarter
  • OVID vs ONC (1 yr)

    In the last 1 year, Beone Medicines Ltd has given 73.9% return, outperforming this stock by 163.6%
  • OVID vs VRTX (3 yr)

    In the last 3 years, Vertex Pharmaceuticals Incorporated has given 53.1% return, outperforming this stock by 142.1%
  • Price to Sales

    ForOVID every $1 of sales, investors are willing to pay $42.1, whereas for Beone Medicines Ltd, the investors are paying $7.1 for every $1 of sales.

Ovid Therapeutics Technicals Summary

Sell

Neutral

Buy

Ovid Therapeutics is currently in a favorable trading position ( BUY ) according to technical analysis indicators.

Ovid Therapeutics (OVID) Vs Peers

Returns
Ratio's
Overview
Company Name1 Month6 Month1 Year3 Years5 Years
Ovid Therapeutics Inc logo
-24.9%
-72.62%
-89.19%
-88.62%
-91.05%
Regeneron Pharmaceuticals, Inc. logo
-8.15%
-36.99%
-33.99%
-12.87%
7.38%
Beone Medicines Ltd logo
-0.1%
17.79%
68.73%
64.3%
51.92%
Vertex Pharmaceuticals Incorporated logo
-1.59%
3.06%
23.79%
83.91%
83.35%
Alnylam Pharmaceuticals, Inc. logo
-9.98%
-14.92%
68.63%
56.35%
69.83%

About Ovid Therapeutics

Ovid Therapeutics Inc., a biopharmaceutical company, engages in the development of impactful medicines for patients and families with epilepsies and seizure-related neurological disorders in the United States. The company is developing OV329, a GABA-AT inhibitor which is in Phase 1 clinical trials for the treatment of adult and pediatric drug-resistant epilepsies; and OV350, a small molecule direct activator of the KCC2 transporter, which is in Phase 1 clinical trials for treating epilepsies. It develops OV350 IV, OV4071, and OV4041, an oral program that behave similarly in phenotypical screens for the treatment of psychosis in people with NSD and LBD; and OV888 (GV101), a highly selective rock2 inhibitor which is in Phase 1 double-blind multiple-ascending dose trial. The company has license and collaboration agreements with Healx, AstraZeneca AB, H. Lundbeck A/S, Northwestern University, and Graviton, as well as Marinus Pharmaceuticals, Inc. The company was incorporated in 2014 and is headquartered in New York, New York.
Organization
Ovid Therapeutics
Employees
23
CEO
Dr. Jeremy Max Levin Ba Zoology, Dphil, M.D., Mb Bchir, Ph.D.
Industry
Health Technology

Management People of Ovid Therapeutics

NameTitle
Dr. Jeremy Max Levin Ba Zoology, Dphil, M.D., Mb Bchir, Ph.D.
CEO & Chairman
Mr. Jeffrey A. Rona
Chief Business and Financial Officer
Ms. Meg Alexander
President & COO
Dr. Dirk Haasner
Senior Vice President of Global Manufacturing & CMC QA
Dr. Julia Tsai Ph.D.
Senior Vice President of Clinical Development
Dr. Toshiya Nishi D.V.M.
Head of Epilepsy Research
Mr. Zhong Zhong Ph.D.
Chief Scientific Officer
Dr. Manal Morsy M.B.A., M.D., PH.D.
Chief Regulatory Officer
Ms. Victoria Fort
Senior Vice President of Corporate Affairs & Corporate Strategy
Mr. Tom Parry
Vice President of Research and Early Development

Important FAQs about investing in OVID Stock from India :

What is Ovid Therapeutics share price today?

Ovid Therapeutics share price today stands at $0.34, Open: $0.35 ; Previous Close: $0.33 ; High: $0.36 ; Low: $0.32 ; 52 Week High: $3.45 ; 52 Week Low: $0.24.

The stock opens at $0.35, after a previous close of $0.33. The stock reached a daily high of $0.36 and a low of $0.32, with a 52-week high of $3.45 and a 52-week low of $0.24.

Can Indians buy Ovid Therapeutics shares?

Yes, Indians can invest in the Ovid Therapeutics (OVID) from India.

With INDmoney, you can buy Ovid Therapeutics at 0 brokerage. The step-by-step process is as follows:

  • Open your zero cost US Stocks account and zero balance IND linked savings a/c (this can be done in less than 3 minutes)
  • Transfer funds to your US Stocks account using your IND linked savings a/c (It takes 24 hours excluding Saturday and Sunday). With INDmoney, you get the best INR USD exchange rates.
  • Once funds are transferred successfully, you can buy Ovid Therapeutics at zero transaction cost.

How can I buy Ovid Therapeutics shares from India?

It is very easy to buy Ovid Therapeutics from India. With INDmoney, you can open a US stocks account in less than 3 minutes. Transfer funds in 24 hours and buy stocks very easily - that too at 0 brokerage. All this is done at 0 account opening & management fee, 0 brokerages, and at the same time you get the best rupee-US dollar exchange rate.

Can Fractional shares of Ovid Therapeutics (OVID) be purchased?

Yes, you can buy fractional shares of Ovid Therapeutics with INDmoney app.

What are the documents required to start investing in Ovid Therapeutics stocks?

To start investing in Ovid Therapeutics, You will need the following documents:

  • Proof of Identification (PAN, Aadhaar etc)
  • Proof of address (Aadhaar, Voter ID etc)

These documents are required as per RBI's guidelines to create your IND linked savings a/c so that you can execute for global fund transfer. The entire process is paperless and can be completed seamlessly.

What are today’s High and Low prices of Ovid Therapeutics Stock (OVID)?

Today’s highest price of Ovid Therapeutics (OVID) is $0.36.

Today’s lowest price of Ovid Therapeutics (OVID) is $0.32.

What is today's market capitalisation of Ovid Therapeutics?

Today's market capitalisation of Ovid Therapeutics OVID is 20.5M

What is the 52 Week High and Low Range of Ovid Therapeutics Stock (OVID)?

  • 52 Week High

    $3.45

  • 52 Week Low

    $0.24

What are the historical returns of Ovid Therapeutics (OVID)?

  • 1 Month Returns

    -24.9%

  • 3 Months Returns

    -72.62%

  • 1 Year Returns

    -89.19%

  • 5 Years Returns

    -91.05%

Who is the Chief Executive Officer (CEO) of Ovid Therapeutics ?

Dr. Jeremy Max Levin Ba Zoology, Dphil, M.D., Mb Bchir, Ph.D. is the current Chief Executive Officer (CEO) of Ovid Therapeutics.